Redefine your XLH treatment with a targeted therapy
X-linked hypophosphatemia (XLH) is a disease where the body doesn’t retain enough phosphorus. Phosphorus is important for bone health, and when there is not enough phosphorus, bones can weaken over time.
CRYSVITA is an FDA-approved therapy that can help the body retain phosphorus and has been evaluated for efficacy and safety in adults and children with XLH.